Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020

Abstract

, new COVID-19 outbreaks have occurred and spread around the world. However, the clinical characteristics of patients in other areas around Wuhan, Hubei Province are still unclear. In this study, we performed epidemiological and clinical characteristics analysis on these regional cases. Methods: We retrospectively investigated COVID-19 patients positively confirmed by nucleic acid Q-PCR at Taihe Hospital from January 16 to February 4, 2020. Their epidemiological, clinical manifestations, and imaging characteristics were analysed. Results: Among the 73 patients studied, 12.3 % developed symptoms after returning to Shiyan from Wuhan, and 71.2 % had a history of close contact with Wuhan personnel or confirmed cases. Among these patients, 9 cases were associated with family clustering. The first main symptoms presented by these patients were fever (84.9 %) and cough (21.9 %). The longest incubation period was 26 days, and the median interval from the first symptoms to admission was 5 days. Of the patients, 67.1 % were originally healthy people with no underlying diseases, others mostly had common comorbidities including hypertension (12.3 %) and diabetes (5.5 %), 10.9 % were current smokers, 30.1 % had low white blood cell counts and 45.2 % showed decreased lymphocytes at the first time of diagnosis. CT scans showed that multiple patchy ground glass shadows outside of the patient lungs were commonly observed, and a single sub-pleural sheet of ground glass shadow with enhanced vascular bundles was also found located under the pleura. Patient follow-up to February 14 presented 38.4 % severe cases and 2.7 % critical cases. After follow-up, the parameter of lymphocyte counts below 0.8 × 10 9 /L cannot be used to predict severe and critical groups from the ordinary group, and a lower proportion of smokers and higher proportion of diabetes patients occur in the poor outcome group. Other co-morbidities are observed but did not lead to poor outcomes. Conclusion: The epidemiological characteristics of patients in the area around Wuhan, such as Shiyan, at first diagnosis are described as follows: Patients had histories of Wuhan residences in the early stage and family clustering in the later period. The incubation period was relatively long, and the incidence was relatively hidden, but the virulence was relatively low. The initial diagnosis of the patients was mostly ordinary, and the percentage of critical patients who evolved into the ICU during follow-up is 2.7 %, which is lower than the 26.1 % reported by Wuhan city. According to the Shiyan experience, early diagnosis with multiple swaps of the Q-PCR test and timely treatment can reduce the death rate. Diabetes could be one of the risk factors for progression to severe/critical outcomes. No evidence exists that smoking protects COVID-19 patients from developing to severe/critical cases, and the absolute number of lymphocytes at initial diagnosis could not predict the progression risk from severe to critical condition. Multivariate regression analysis should be used to furt...

Smoking and COVID-19: Adding Fuel to the Flame

“…More findings by Kim et al [42] in a recent Korean cohort study with 28 hospitalized patients with confirmed COVID-19 in which only 5 of the patients out of 27 (18.5%) had any smoking history. Another study by Zheng et al [43] reported that only 10.9% of all patients in the study were smokers, but 6.7% were smokers in the severe/critically ill group, which is not significantly (χ 2 = 0.962, p > 0.05) lower than of the ordinary group with 14.0%. They further concluded that no evidence exists that smoking protects COVID-19 patients from developing to severe disease.…”

A comparison of COVID-19, SARS and MERS

“…A total of 3.8% of confirmed COVID-19 patients were health workers (Aggarwal, Lippi & Michael Henry, 2020). Diabetes could be one of the risk factors for progression to severe/critical outcomes (Zheng et al, 2020). Human-human transmission is considered a major transmission mode of COVID-19 by the sixth version of the Guidance for Diagnosis and Treatments for COVID-19 issued by the National Health Commission of China.…”

“…According to a study among 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, the male-to-female ratio was 1.06:1, and the median age was 56 years (interquartile range, 42–68; range, 22–92 years) ( Wu & McGoogan, 2020 ; Wang et al, 2020 ). Of the 1,591 patients requiring treatment in an intensive care unit (ICU) in the Lombardy region of Italy, the median (IQR) age was 63 ( Richardson et al, 2020 ; Borghesi et al, 2020 ; Zheng et al, 2020 ; De Wit et al, 2016 ; Gao et al, 2016 ) years, and 1,304 (82%) were male ( Grasselli et al, 2020 ). According to the data from 5,700 hospitalized patients with confirmed COVID-19 in New York City, the median age was 63 years (interquartile range, 52–75; range, 0–107 years), and 39.7% were female ( Richardson et al, 2020 ).…”

Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids?

“…This scenario clearly suggests that the clinical profile of potentially infected subjects is crucial in the knowledge and prompt diagnosis of COVID-19. In this respect, comorbidities and clinical signs of COVID-19 patients have been included in epidemiological studies, although reported mainly as descriptive statistics [2,[4][5][6][7][8][9][10][11][12][13] even in very large investigations [14].…”